Infections and atherosclerosis: new clues from an old hypothesis?
暂无分享,去创建一个
[1] W. Ophüls. Arteriosclerosis, Cardiovascular Disease Their Relation to Infectious Diseases , 2009 .
[2] D. Smith,et al. CHRONIC INFECTIONS AND CORONARY HEART DISEASE , 1999, International journal of clinical practice.
[3] D. Graham,et al. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. , 1998, Circulation.
[4] P. Libby,et al. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. , 1998, Circulation.
[5] J. Grayston,et al. Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events. , 1998, Circulation.
[6] P. Ridker. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? , 1998, Circulation.
[7] J. Mehta,et al. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. , 1998, Journal of the American College of Cardiology.
[8] V. Fuster,et al. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. , 1998, Circulation.
[9] C. Hennekens. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. , 1998, Circulation.
[10] A. C. Nicholson,et al. Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[11] M. Nieminen,et al. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] D. Weed,et al. Biologic plausibility in causal inference: current method and practice. , 1998, American journal of epidemiology.
[13] J. Carlquist,et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. , 1998, Circulation.
[14] P. Libby,et al. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. , 1997, Circulation.
[15] E. Braunwald. Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.
[16] M. Leinonen,et al. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits , 1997, Infection and immunity.
[17] Qingbo Xu,et al. Atherosclerosis, autoimmunity, and vascular‐associated lymphoid tissue , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] D. Barker,et al. Intrauterine programming of coronary heart disease and stroke , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[19] I. Fong,et al. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. , 1997, Circulation.
[20] P. Sorlie,et al. Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link? , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[21] P. Berger. Symptoms of chronic bronchitis and the risk of coronary disease , 1997 .
[22] J. Danesh,et al. Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.
[23] G. Lip,et al. Can we treat coronary artery disease with antibiotics? , 1997, The Lancet.
[24] E. Gurfinkel,et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study , 1997, The Lancet.
[25] M. Leinonen,et al. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. , 1997, International journal of epidemiology.
[26] A. Camm,et al. Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial Infarction , 1997 .
[27] M. Leinonen,et al. Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease. , 1997, European heart journal.
[28] P. Vallance,et al. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? , 1997, The Lancet.
[29] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[30] A. Maseri. Inflammation, atherosclerosis, and ischemic events -- exploring the hidden side of the moon. , 1997, The New England journal of medicine.
[31] G. Rodgers,et al. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[32] L. Campbell,et al. Murine models of Chlamydia pneumoniae infection and atherosclerosis. , 1997, The Journal of infectious diseases.
[33] J. Parsonnet,et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. , 1997, The New England journal of medicine.
[34] S. Shahgasempour,et al. Alterations in the Expression of ELAM‐1, ICAM‐1 and VCAM‐1 after In Vitro Infection of Endothelial Cells with a Clinical Isolate of Human Cytomegalovirus , 1997, Microbiology and immunology.
[35] E. Leatham,et al. The relation between Chlamydia pneumoniae and atherosclerosis. , 1997, Heart.
[36] J. Salonen,et al. Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? , 1996, American journal of epidemiology.
[37] F. Blasi,et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms , 1996, Journal of clinical microbiology.
[38] G. Vercellotti,et al. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. , 1996, The American journal of pathology.
[39] S. Epstein,et al. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. , 1996, The Journal of clinical investigation.
[40] P. Vokonas,et al. Periodontal Disease and Cardiovascular Disease. , 1996, Journal of periodontology.
[41] P. Sorlie,et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. , 1996, Circulation.
[42] M. Leinonen,et al. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. , 1996, Microbial pathogenesis.
[43] J. Ramirez,et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells , 1996, Infection and immunity.
[44] M Susser,et al. Choosing a future for epidemiology: I. Eras and paradigms. , 1996, American journal of public health.
[45] M Susser,et al. Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. , 1996, American journal of public health.
[46] B. Davidson,et al. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. , 1996, Journal of clinical pathology.
[47] R. Wissler. Significance of Chlamydia pneumoniae (TWAR) in atherosclerotic lesions. , 1995, Circulation.
[48] T. Shenk,et al. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. , 1995, Journal of virology.
[49] D. Stewart,et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. , 1995, The Journal of infectious diseases.
[50] B. McManus,et al. Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. , 1995, The American journal of pathology.
[51] M. Szklo,et al. Social inequalities and atherosclerosis. The atherosclerosis risk in communities study. , 1995, American journal of epidemiology.
[52] W. Busse. Viral Infections of Humans , 1976, Springer US.
[53] G. Dahlén,et al. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. , 1995, Atherosclerosis.
[54] Sutter Mc. Lessons for atherosclerosis research from tuberculosis and peptic ulcer , 1995 .
[55] D. Barker,et al. Weight in infancy and prevalence of coronary heart disease in adult life , 1995, BMJ.
[56] J. F. Wright,et al. Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. , 1994, Blood.
[57] S. Plotkin. Vaccines for varicella-zoster virus and cytomegalovirus: recent progress. , 1994, Science.
[58] M. Leon,et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. , 1994, Science.
[59] D. Graham,et al. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. , 1994, Gut.
[60] M. Wegman. Causation and Disease: A Chronological Journey , 1994 .
[61] M. Debakey,et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis , 1994, Journal of medical virology.
[62] C Osmond,et al. Early growth and death from cardiovascular disease in women. , 1993, BMJ.
[63] E. Benditt,et al. Chlamydia pneumoniae, strain TWAR and atherosclerosis. , 1993, European heart journal.
[64] M. Nieminen,et al. Infection and inflammation as risk factors for myocardial infarction. , 1993, European heart journal.
[65] M. Muldoon. Coronary Heart Disease Epidemiology: From Aetiology to Public Health , 1993 .
[66] Qingbo Xu,et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.
[67] V. V. van Hinsbergh,et al. The Procoagulant Response of Cytomegalovirus Infected Endothelial Cells , 1992, Thrombosis and Haemostasis.
[68] D. Siscovick,et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. , 1992, JAMA.
[69] P. Saikku,et al. The epidemiology and significance of Chlamydia pneumoniae. , 1992, The Journal of infection.
[70] M. Leinonen,et al. Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study , 1992, Annals of Internal Medicine.
[71] C. Bruggeman,et al. Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers. , 1991, Immunology.
[72] H. Friedman,et al. Viral activation of the coagulation cascade: Molecular interactions at the surface of infected endothelial cells , 1990, Cell.
[73] M. Debakey,et al. Possible role of cytomegalovirus in atherogenesis. , 1990, JAMA.
[74] P. Saikku,et al. A NEW RESPIRATORY TRACT PATHOGEN: CHLAMYDIA PNEUMONIAE STRAIN TWAR , 1990, The Journal of infectious diseases.
[75] C. Bruggeman,et al. The effect of cytomegalovirus infection on the adherence of polymorphonuclear leucocytes to endothelial cells , 1989, European journal of clinical investigation.
[76] V. Starnes,et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. , 1989, JAMA.
[77] M. Nieminen,et al. SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.
[78] R. Pasternak,et al. The potential role of viruses in the pathogenesis of atherosclerosis. , 1988, Circulation.
[79] C. Bruggeman,et al. Cytomegalovirus Alters the von Willebrand Factor Content in Human Endothelial Cells , 1988, Thrombosis and Haemostasis.
[80] K. Bailey,et al. HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS , 1987, The Lancet.
[81] J. Trentin,et al. Replication of cytomegalovirus in human arterial smooth muscle cells , 1985, Journal of virology.
[82] P. Saikku,et al. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. , 1985, The Journal of infectious diseases.
[83] C. Minick,et al. Herpesvirus-induced atherosclerosis in chickens. , 1983, Federation proceedings.
[84] C. Buck,et al. Infant diarrhoea and subsequent mortality from heart disease and cancer. , 1982, Journal of epidemiology and community health.
[85] M. Marmot,et al. Social class and coronary heart disease. , 1981, British heart journal.
[86] C. Minick,et al. Brief Definitive Report , 2003 .
[87] P. Middleton. Viral Infections of Humans. Epidemiology and Control. , 1978 .
[88] T. Pearson,et al. Clonal characteristics of fibrous plaques and fatty streaks from human aortas. , 1975, The American journal of pathology.
[89] A. Keys. Coronary heart disease--the global picture. , 1975, Atherosclerosis.
[90] J. Gillespie,et al. Virus-Induced Cholesterol Crystals , 1973, Science.
[91] E. Benditt,et al. Evidence for a monoclonal origin of human atherosclerotic plaques. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[92] A. Lilienfeld. Epidemiology of infectious and non-infectious disease: some comparisons. , 1973, American journal of epidemiology.
[93] D. I. Abramson. Diseases of the Arteries , 1970 .
[94] Miracle Drugs: A History of Antibiotics , 1964 .
[95] W. Kannel,et al. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.
[96] H. T. Karsner,et al. Coronary arteries in rheumatic fever , 1934 .
[97] O. Klotz. Fatty Degeneration of the Intima of Arteries. , 1915, The Journal of medical research.
[98] C. Frothingham. THE RELATION BETWEEN ACUTE INFECTIOUS DISEASES AND ARTERIAL LESIONS , 1911 .
[99] W. S. Thayer,et al. THE RELATION OF ACUTE INFECTIONS TO ARTERIOSCLEROSIS. , 1904 .
[100] W. S. Thayer. ON THE LATE EFFECTS OF TYPHOID FEVER ON THE HEART AND VESSELS: A CLINICAL STUDY , 1904 .
[101] R. Virchow,et al. Cellular Pathology, as Based upon Physiological and Pathological Histology , 1860, Nutrition reviews.
[102] G. Vetrovec,et al. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. , 1998, The Journal of infectious diseases.
[103] K. Joseph,et al. Review of the evidence on fetal and early childhood antecedents of adult chronic disease. , 1996, Epidemiologic reviews.
[104] S. Adler. Current prospects for immunization against cytomegaloviral disease. , 1996, Infectious agents and disease.
[105] L. Kuller,et al. ORIGINAL CONTRIBUTIONS Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study , 1996 .
[106] R. Alexander. Inflammation and coronary artery disease. , 1994, The New England journal of medicine.
[107] G. Vercellotti. Proinflammatory and procoagulant effects of herpes simplex infection on human endothelium. , 1990, Blood cells.
[108] V. Valtonen,et al. Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins. , 1990, Annals of medicine.
[109] T. Thom,et al. Trends in CHD in the United States. , 1989, International journal of epidemiology.
[110] G. Rose,et al. Causes of the trends and variations in CHD mortality in different countries. , 1989, International journal of epidemiology.
[111] A. Robertson,et al. Herpesviridae in the coronary arteries and aorta of young trauma victims. , 1988, The American journal of pathology.
[112] R. Cotran,et al. The pathogenesis of atherosclerosis: atherogenesis and inflammation. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[113] D. Hajjar,et al. Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. , 1986, The American journal of pathology.
[114] M. Lopes-Virella,et al. Immunological and microbiological factors in the pathogenesis of atherosclerosis. , 1985, Clinical immunology and immunopathology.
[115] J. Eyer. Changing trends in ischemic heart disease: relations to cohort experience and economic trends in industrial countries. , 1982, Advances in cardiology.
[116] T. Pearson,et al. Clonal characteristics of cutaneous scars and implications for atherogenesis. , 1981, The American journal of pathology.
[117] G. Majno,et al. Atherosclerosis and inflammation. , 1978, Advances in experimental medicine and biology.
[118] T. Norwood,et al. Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. , 1974, The American journal of pathology.
[119] P. Sartwell. "On the methodology of investigations of etiologic factors in chronic diseases"--further comments. , 1960, Journal of chronic diseases.
[120] N. Jones,et al. THE INCIDENCE OF STREPTOCOCCAL INFECTION IN CARDIOVASCULAR SCLEROSIS , 1935 .
[121] E. V. Cowdry,et al. Arteriosclerosis : a survey of the problem , 1933 .